Qian Shi1, Shuqian Liu1, Marie Krousel-Wood2, Hui Shao1, Vivian Fonseca3, Lizheng Shi4. 1. Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, United States. 2. Department of Medicine, School of Medicine and Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, United States. 3. Section of Endocrinology, Department of Medicine, School of Medicine, Tulane University, United States. 4. Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, United States; Section of Endocrinology, Department of Medicine, School of Medicine, Tulane University, United States. Electronic address: lshi1@tulane.edu.
Abstract
AIMS: This study was designed to compare the risk of long-term health outcomes, including microvascular, macrovascular complications and mortality, across 4 cohorts: triple-goal, dual-goal, single-goal, and no-goal achievers. METHODS: A retrospective cohort of 53,120 patients with T2DM were identified (97.51% male, 61.49% whites) from the Veterans Affairs (VA) electronic medical records VISN 16 data warehouse (2004-2010). Propensity score weight (PSW) was used to balance demographic characteristics and complication history at baseline. The PSW adjusted hazard ratios (aHR) from Cox proportional hazard models were used to compare complications and all-cause mortality over an average of 4 years of follow-up. RESULTS: At baseline, 25.43% (13,507) patients achieved triple-goal, while 41.36% (21,972) and 26.37% (14,010) patients achieved dual-goal and single-goal, respectively. During the follow-up period, triple-goal achievement was associated with risk reductions of complications and all-cause mortality when compared to all other groups of achieving dual or single-goal. Across different combinations of dual-goal achievement, the cohort with LDL-C goal achievement had lower risk of complication events and mortality, compared to those that achieved other goals but failed to reach LDL-C goal. CONCLUSIONS: Achievement of triple-goal was associated with better health outcomes among veterans with T2DM compared to those that did not, while LDL-C has more weight of influence. Multi-faceted treatment strategies targeting hypertension, hyperglycemia and hyperlipidemia may improve health outcome in veterans with T2DM.
AIMS: This study was designed to compare the risk of long-term health outcomes, including microvascular, macrovascular complications and mortality, across 4 cohorts: triple-goal, dual-goal, single-goal, and no-goal achievers. METHODS: A retrospective cohort of 53,120 patients with T2DM were identified (97.51% male, 61.49% whites) from the Veterans Affairs (VA) electronic medical records VISN 16 data warehouse (2004-2010). Propensity score weight (PSW) was used to balance demographic characteristics and complication history at baseline. The PSW adjusted hazard ratios (aHR) from Cox proportional hazard models were used to compare complications and all-cause mortality over an average of 4 years of follow-up. RESULTS: At baseline, 25.43% (13,507) patients achieved triple-goal, while 41.36% (21,972) and 26.37% (14,010) patients achieved dual-goal and single-goal, respectively. During the follow-up period, triple-goal achievement was associated with risk reductions of complications and all-cause mortality when compared to all other groups of achieving dual or single-goal. Across different combinations of dual-goal achievement, the cohort with LDL-C goal achievement had lower risk of complication events and mortality, compared to those that achieved other goals but failed to reach LDL-C goal. CONCLUSIONS: Achievement of triple-goal was associated with better health outcomes among veterans with T2DM compared to those that did not, while LDL-C has more weight of influence. Multi-faceted treatment strategies targeting hypertension, hyperglycemia and hyperlipidemia may improve health outcome in veterans with T2DM.
Authors: Alice P S Kong; Xilin Yang; Gary T C Ko; Wing-Yee So; Wing-Bun Chan; Ronald C W Ma; Vanessa W S Ng; Chun-Chung Chow; Clive S Cockram; Peter C Y Tong; Vivian Wong; Juliana C N Chan Journal: Diabetes Care Date: 2007-01-26 Impact factor: 19.112
Authors: William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245
Authors: Henry N Ginsberg; Marshall B Elam; Laura C Lovato; John R Crouse; Lawrence A Leiter; Peter Linz; William T Friedewald; John B Buse; Hertzel C Gerstein; Jeffrey Probstfield; Richard H Grimm; Faramarz Ismail-Beigi; J Thomas Bigger; David C Goff; William C Cushman; Denise G Simons-Morton; Robert P Byington Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245
Authors: Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams Journal: Lancet Date: 2007-09-08 Impact factor: 79.321
Authors: Walter Masson; Melina Huerín; Lorenzo Martin Lobo; Gerardo Masson; Graciela Molinero; Mariano Nemec; Mariela Boccadoro; Cinthia Romero; Gabriel Micali; Daniel Siniawski Journal: J Cardiovasc Dev Dis Date: 2020-02-05
Authors: Rubén Silva-Tinoco; Teresa Cuatecontzi-Xochitiotzi; Viridiana De la Torre-Saldaña; Enrique León-García; Javier Serna-Alvarado; Eileen Guzmán-Olvera; Dolores Cabrera; Juan G Gay; Diddier Prada Journal: Int J Equity Health Date: 2020-05-24
Authors: Addie L Fortmann; Athena Philis-Tsimikas; Johanna A Euyoque; Taylor L Clark; Daniela G Vital; Haley Sandoval; Julia I Bravin; Kimberly L Savin; Jennifer A Jones; Scott Roesch; Todd Gilmer; Thomas Bodenheimer; James Schultz; Linda C Gallo Journal: Contemp Clin Trials Date: 2020-10-11 Impact factor: 2.226